Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Association between genetic polymorphisms and bleeding risk of apixaban in Thai patients with atrial fibrillation
TCTR20260524002Not yet recruiting
- Sponsor
- Krit Wattanathum
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of apixaban in Atrial fibrillation (AFib), sponsored by Krit Wattanathum. Primary endpoint: Bleeding events associated with apixaban. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on TCTR20260524002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260524002.